Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing
BEIJING, Dec. 18, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2025. Highlights for the Quarter...
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
Transition from An Asset-Heavy Business Model to An Asset-Light Business Model Achieved Quarterly Non-GAAP Net Profitability Maintained Non-GAAP Operational Profitability for Three Consecutive Quarter s Achieved Quarterly Positive Operating Cash...
IAAPA Announces Global Partnership with Expression Capital Partners to Support Growth and Investment Across the Attractions Industry
ORLANDO, Fla., Dec. 17, 2025 /PRNewswire/ -- IAAPA, the premier association representing the global attractions industry, has announced a new global partnership with Expression Capital Partners LLP, marking a significant investment in the long-term...
Seagull Watch Unveils New Rattrapante Chronograph and Announces Global Official Website Launch
The legacy of the iconic Seagull 1963 evolves with the brand's first split-seconds complication, offering haute horology at an accessible price point as Seagull Watch accelerates its global strategy. TIANJIN, China, Dec. 16, 2025 /PRNewswire/ --...
L&D Tech Selected as a World-Class Product with Its Energy-Saving LED Display; Receives Prime Minister's Award and Announces Global Launch
Awarded the Prime Minister's Prize for New Technology Commercialization at the Industrial Technology Merit Awards, validating its technological excellence and reliability Proprietary 3D-structured lens technology reduces light pollution and cuts...
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization - Exclusive Greater China license to develop and...
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ -- HanchorBio Inc....
Hullo Announces Major Upgrade to Its AI Matchmaking System, Backed by Participation in Nvidia Inception, AWS Activate, and Google for Startups
The upgraded platform delivers a smarter AI Matchmaking system that reduces swipe fatigue and improves meaningful connections worldwide. HO CHI MINH CITY, Vietnam, Dec. 11, 2025 /PRNewswire/ -- Hullo Dating Co., Ltd today announced a major upgrade...
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS
- Head of Data Innovation Center presents STRADVISION's next roadmap at AWS re:Invent SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- STRADVISION, a global leader in AI-based vision perception technology for vehicles, today announced its...